
P1374: EASIX ASSESSED AT 1 YEAR AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION PREDICTS THE ONSET OF SUBSEQUENT NON‐RELAPSE MORTALITY
Author(s) -
Takeda R.,
Shibasaki Y.,
Katagiri T.,
Fuse K.,
Sone H.,
Masuko M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848356.02054.02
Subject(s) - medicine , transplantation , total body irradiation , hematopoietic stem cell transplantation , comorbidity , myeloid leukemia , leukemia , hematopoietic cell , disease , oncology , gastroenterology , surgery , haematopoiesis , stem cell , chemotherapy , biology , genetics , cyclophosphamide